U.S. Vaccine Program Now Flush With Cash, but Short on Key Details
A $5 billion federal program aims to make better Covid vaccines. But vaccine makers are confused by murky regulatory guidance.
Stay updated with breaking news from Project Nextgen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A $5 billion federal program aims to make better Covid vaccines. But vaccine makers are confused by murky regulatory guidance.
From the column: "We all need to be sensitive to the needs and fears of those among us who are at risk of serious illness from COVID. We still have work to do."
Many immunocompromised and older people are still terrified of COVID. As a transplant infectious disease doctor on the front lines, I understand why. In the first five months of 2023, COVID caused more than 37,000 deaths in the US, a typical toll from the flu in an entire year. Scientists estimate an annual US COVID death rate of at
Government officials, lawmakers and health policy experts said the U.S. is prepared for the next pandemic but also detailed health care challenges.
The elderly population remains most vulnerable: